Establishment Labs Holdings Inc. Cost of Revenue
Establishment Labs Holdings Inc. (ESTA) reported Cost of Revenue of $19.83 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement
us-gaap:CostOfRevenue · last filed 2026-08-07
- Establishment Labs Holdings Inc. cost of revenue for the quarter ending 2026-06-30 was $19.83M, a 23.73% increase year-over-year.
- Establishment Labs Holdings Inc. cost of revenue for the quarter ending 2026-03-31 was $17.54M, a 29.28% increase year-over-year.
- Establishment Labs Holdings Inc. cost of revenue for the quarter ending 2025-12-31 was $19.09M, a 36.11% increase year-over-year.
- Establishment Labs Holdings Inc. cost of revenue for the quarter ending 2025-09-30 was $16.09M, a 10.86% increase year-over-year.
- Establishment Labs Holdings Inc. cost of revenue for fiscal 2025 was $64.77M, a 14.63% increase from fiscal 2024.
- Establishment Labs Holdings Inc. cost of revenue for fiscal 2024 was $56.50M, a 2.88% decline from fiscal 2023.
- Establishment Labs Holdings Inc. cost of revenue for fiscal 2023 was $58.17M, a 5.57% increase from fiscal 2022.
- Establishment Labs Holdings Inc. cost of revenue for fiscal 2022 was $55.10M, a 33.50% increase from fiscal 2021.
| Period end | Cost of Revenue 3 month | Cost of Revenue 6 month | Cost of Revenue 9 month | Cost of Revenue 12 month |
|---|---|---|---|---|
| 2026-06-30 | $19.83M 10-Q · filed 2026-08-07 | $37.37M 10-Q · filed 2026-08-07 | $56.46M derived: sum of 3 quarters · filed 2026-08-07 | $72.54M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $17.54M 10-Q · filed 2026-05-08 | $36.63M derived: sum of 2 quarters · filed 2026-05-08 | $52.71M derived: sum of 3 quarters · filed 2026-05-08 | $68.74M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $19.09M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $35.17M derived: sum of 2 quarters · filed 2026-02-27 | $51.20M derived: sum of 3 quarters · filed 2026-08-07 | $64.77M 10-K · filed 2026-02-27 |
| 2025-09-30 | $16.09M 10-Q · filed 2025-11-07 | $32.11M derived: sum of 2 quarters · filed 2026-08-07 | $45.68M 10-Q · filed 2025-11-07 | $59.70M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $16.03M 10-Q · filed 2026-08-07 | $29.60M 10-Q · filed 2026-08-07 | $43.62M derived: sum of 3 quarters · filed 2026-08-07 | $58.13M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $13.57M 10-Q · filed 2026-05-08 | $27.59M derived: sum of 2 quarters · filed 2026-05-08 | $42.10M derived: sum of 3 quarters · filed 2026-05-08 | $57.28M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $14.02M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $28.53M derived: sum of 2 quarters · filed 2026-02-27 | $43.71M derived: sum of 3 quarters · filed 2026-02-27 | $56.50M 10-K · filed 2026-02-27 |
| 2024-09-30 | $14.51M 10-Q · filed 2025-11-07 | $29.69M derived: sum of 2 quarters · filed 2025-11-07 | $42.48M 10-Q · filed 2025-11-07 | $53.45M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $15.18M 10-Q · filed 2025-08-07 | $27.97M 10-Q · filed 2025-08-07 | $38.94M derived: sum of 3 quarters · filed 2026-02-27 | $51.40M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $12.79M 10-Q · filed 2025-05-09 | $23.76M derived: sum of 2 quarters · filed 2026-02-27 | $36.22M derived: sum of 3 quarters · filed 2026-02-27 | $54.52M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $10.97M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $23.43M derived: sum of 2 quarters · filed 2026-02-27 | $41.73M derived: sum of 3 quarters · filed 2026-02-27 | $58.17M 10-K · filed 2026-02-27 |
| 2023-09-30 | $12.45M 10-Q · filed 2024-11-12 | $30.75M derived: sum of 2 quarters · filed 2024-11-12 | $47.20M 10-Q · filed 2024-11-12 | $62.85M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $18.30M 10-Q · filed 2024-08-07 | $34.74M 10-Q · filed 2024-08-07 | $50.39M derived: sum of 3 quarters · filed 2025-02-28 | $62.60M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $16.45M 10-Q · filed 2024-05-09 | $32.09M derived: sum of 2 quarters · filed 2025-02-28 | $44.30M derived: sum of 3 quarters · filed 2025-02-28 | $58.03M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $15.65M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $27.85M derived: sum of 2 quarters · filed 2025-02-28 | $41.59M derived: sum of 3 quarters · filed 2025-02-28 | $55.10M 10-K · filed 2025-02-28 |
| 2022-09-30 | $12.21M 10-Q · filed 2023-11-08 | $25.94M derived: sum of 2 quarters · filed 2023-11-08 | $39.46M 10-Q · filed 2023-11-08 | $50.54M derived: sum of 4 quarters · filed 2024-03-04 |
| 2022-06-30 | $13.74M 10-Q · filed 2023-08-09 | $27.25M 10-Q · filed 2023-08-09 | $38.34M derived: sum of 3 quarters · filed 2024-03-04 | $47.76M derived: sum of 4 quarters · filed 2024-03-04 |
| 2022-03-31 | $13.52M 10-Q · filed 2023-05-10 | $24.60M derived: sum of 2 quarters · filed 2024-03-04 | $34.02M derived: sum of 3 quarters · filed 2024-03-04 | $44.55M derived: sum of 4 quarters · filed 2024-03-04 |
| 2021-12-31 | $11.09M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-04 | $20.51M derived: sum of 2 quarters · filed 2024-03-04 | $31.03M derived: sum of 3 quarters · filed 2024-03-04 | $41.28M 10-K · filed 2024-03-04 |
| 2021-09-30 | $9.42M 10-Q · filed 2022-11-09 | $19.95M derived: sum of 2 quarters · filed 2022-11-09 | $30.19M 10-Q · filed 2022-11-09 | $42.51M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $10.53M 10-Q · filed 2022-08-09 | $20.77M 10-Q · filed 2022-08-09 | $33.09M derived: sum of 3 quarters · filed 2023-03-01 | $40.70M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $10.25M 10-Q · filed 2022-05-10 | $22.57M derived: sum of 2 quarters · filed 2023-03-01 | $30.18M derived: sum of 3 quarters · filed 2023-03-01 | $33.42M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $12.32M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $19.93M derived: sum of 2 quarters · filed 2023-03-01 | $23.17M derived: sum of 3 quarters · filed 2023-03-01 | $32.17M 10-K · filed 2023-03-01 |
| 2020-09-30 | $7.61M 10-Q · filed 2021-11-09 | $10.85M derived: sum of 2 quarters · filed 2021-11-09 | $19.86M 10-Q · filed 2021-11-09 | $27.75M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $3.24M 10-Q · filed 2021-07-30 | $12.24M 10-Q · filed 2021-07-30 | $20.13M derived: sum of 3 quarters · filed 2022-03-01 | $28.75M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $9.00M 10-Q · filed 2021-05-06 | $16.89M derived: sum of 2 quarters · filed 2022-03-01 | $25.51M derived: sum of 3 quarters · filed 2022-03-01 | $34.18M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $7.89M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $16.51M derived: sum of 2 quarters · filed 2022-03-01 | $25.18M derived: sum of 3 quarters · filed 2022-03-01 | $34.70M 10-K · filed 2022-03-01 |
| 2019-09-30 | $8.62M 10-Q · filed 2020-11-09 | $17.29M derived: sum of 2 quarters · filed 2020-11-09 | $26.81M 10-Q · filed 2020-11-09 | $33.34M derived: sum of 4 quarters · filed 2020-11-09 |
| 2019-06-30 | $8.67M 10-Q · filed 2020-08-07 | $18.20M 10-Q · filed 2020-08-07 | $24.72M derived: sum of 3 quarters · filed 2020-08-07 | $30.89M derived: sum of 4 quarters · filed 2020-08-07 |
| 2019-03-31 | $9.53M 10-Q · filed 2020-05-08 | $16.05M derived: sum of 2 quarters · filed 2020-05-08 | $22.22M derived: sum of 3 quarters · filed 2020-05-08 | $27.71M derived: sum of 4 quarters · filed 2020-05-08 |
| 2018-12-31 | $6.52M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $12.70M derived: sum of 2 quarters · filed 2020-03-16 | $18.19M derived: sum of 3 quarters · filed 2020-03-16 | $25.09M 10-K · filed 2020-03-16 |
| 2018-09-30 | $6.17M 10-Q · filed 2019-11-12 | $11.66M derived: sum of 2 quarters · filed 2019-11-12 | $18.57M 10-Q · filed 2019-11-12 | $23.81M derived: sum of 4 quarters · filed 2019-11-12 |
| 2018-06-30 | $5.49M 10-Q · filed 2019-08-13 | $12.39M 10-Q · filed 2019-08-13 | $17.64M derived: sum of 3 quarters · filed 2019-08-13 | $21.36M derived: sum of 4 quarters · filed 2019-08-13 |
| 2018-03-31 | $6.90M 10-Q · filed 2019-05-15 | $12.15M derived: sum of 2 quarters · filed 2019-05-15 | $15.87M derived: sum of 3 quarters · filed 2019-05-15 | $20.37M derived: sum of 4 quarters · filed 2019-05-15 |
| 2017-12-31 | $5.25M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-20 | $8.97M derived: sum of 2 quarters · filed 2019-03-20 | $13.47M derived: sum of 3 quarters · filed 2019-03-20 | $16.98M 10-K · filed 2019-03-20 |
| 2017-09-30 | $3.72M 10-Q · filed 2018-11-13 | $8.22M derived: sum of 2 quarters · filed 2018-11-13 | $11.73M 10-Q · filed 2018-11-13 | |
| 2017-06-30 | $4.50M 10-Q · filed 2018-09-13 | $8.01M 10-Q · filed 2018-09-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B | |
| NutriBand Inc. (NTRB) | United States | $0.109B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |